Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients (MultiSENSE)
- Conditions
- heart Fialure10019280
- Registration Number
- NL-OMON37715
- Lead Sponsor
- Boston Scientific
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Age 18 or above, or of legal age to give informed consent specific to state and national law;Willing and capable of returning for all follow-up visits and emergency care at the investigational center, as medically appropriate;Willing to participate in all testing associated with this clinical investigation at an approved clinical investigational center;Currently implanted with a CRT-D system including a COGNIS device (Model N119, N120, P107 or P108) with RA, RV, and LV leads;Classified as NYHA Class II, III, or IV within the last 6 months
Inability or refusal to sign the Patient Informed Consent
Inability or refusal to comply with the follow-up schedule
Documented as pacemaker dependent
Unable to rest comfortably in a semi-recumbent position for up to 20 minutes
Implanted with active Medtronic Fidelis® lead models: 6930, 6931, 6948 or 6949
Currently implanted with unipolar RA, RV, or LV leads
LV sensitivity programmed to <0.7mV AGC
Subjects that have a history of appropriate Tachycardia Therapy (external or implanted) for rates <165 bpm within 1 week prior to enrollment
Device battery status indicates approximate time to explant <2 years
Likely to undergo lead or PG revision during the course of the study as determined by the Investigator
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>It is estimated that approximately 100 events will be required for developing a<br /><br>multisensory algorithm for the early detection of HF events. </p><br>
- Secondary Outcome Measures
Name Time Method <p>NVT</p><br>